Seguir
Richard Keefe
Richard Keefe
Professor of Psychiatry and Behavioral Sciences
Dirección de correo verificada de duke.edu
Título
Citado por
Citado por
Año
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ...
New England journal of medicine 353 (12), 1209-1223, 2005
71912005
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
21842008
Persistent cannabis users show neuropsychological decline from childhood to midlife
MH Meier, A Caspi, A Ambler, HL Harrington, R Houts, RSE Keefe, ...
Proceedings of the National Academy of Sciences 109 (40), E2657-E2664, 2012
17742012
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
RSE Keefe, TE Goldberg, PD Harvey, JM Gold, MP Poe, L Coughenour
Schizophrenia research 68 (2-3), 283-297, 2004
14452004
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
13242007
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ...
American Journal of Psychiatry 163 (4), 600-610, 2006
11722006
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
10722004
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis
RSE Keefe, SG Silva, DO Perkins, JA Lieberman
Schizophrenia bulletin 25 (2), 201-222, 1999
9951999
Antipsychotic drug effects on brain morphology in first-episode psychosis
JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ...
Archives of general psychiatry 62 (4), 361-370, 2005
9322005
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
PD Harvey, RSE Keefe
American journal of psychiatry 158 (2), 176-184, 2001
8472001
Schizophrenia is a cognitive illness: time for a change in focus
RS Kahn, RSE Keefe
JAMA psychiatry 70 (10), 1107-1112, 2013
8012013
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
7232008
Barriers to employment for people with schizophrenia
R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ...
American Journal of Psychiatry 163 (3), 411-417, 2006
6182006
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study
A Reichenberg, A Caspi, HL Harrington, R Houts, RSE Keefe, RM Murray, ...
American Journal of Psychiatry 167 (2), 160-169, 2010
6062010
How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
RSE Keefe, WS Fenton
Schizophrenia bulletin 33 (4), 912-920, 2007
5682007
Baseline neurocognitive deficits in the CATIE schizophrenia trial
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
5672006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ...
American Journal of Psychiatry 163 (4), 611-622, 2006
5652006
Cognitive impairment in schizophrenia
RSE Keefe, PD Harvey
Novel antischizophrenia treatments, 11-37, 2012
5582012
A genome-wide investigation of SNPs and CNVs in schizophrenia
AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ...
PLoS genetics 5 (2), e1000373, 2009
5502009
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
5392005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20